A review of a recently published guidelines' “strong recommendation” for therapeutic drug monitoring of olanzapine, haloperidol, perphenazine, and fluphenazine

INTRODUCTION: In addition to clozapine, there is a growing body of evidence that supports therapeutic drug monitoring (TDM) for additional antipsychotics commonly used in the United States. METHODS: The Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) published TDM gui...

Descripción completa

Detalles Bibliográficos
Autor principal: Noel, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2019
Materias:
Literature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607953/
https://www.ncbi.nlm.nih.gov/pubmed/31293849
http://dx.doi.org/10.9740/mhc.2019.07.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607953/
https://www.ncbi.nlm.nih.gov/pubmed/31293849
http://dx.doi.org/10.9740/mhc.2019.07.287

Ejemplares similares